Our Blog

What a doctor wants you to know about memory tests and early symptoms of Alzheimer’s

What a Doctor Wants You to know about Memory Tests and Early Symptoms of Alzheimer’s Dr Emer MacSweeney, CEO and Medical Director at Re:Cognition Health shares her […]

Is your lifestyle increasing your risk of dementia?

Dr Emer MacSweeney, Consultant Neuroradiologist and CEO at Re:Cognition Health spoke with Health Tech World about how our  lifestyle choices may be increasing our risk of dementia. Recent research […]

Psychiatric drugs for reducing Alzheimer’s risk

Psychiatric Drugs for Reducing Alzheimer’s Risk Dr Tom MacLaren speaks with Medical News Today At Re:Cognition Health, we are passionate about research and dedicated to helping more […]

Can darts really help your brain?

Can darts really help your brain? Whilst many people enjoy a social game of darts at the pub, is it just a recreational activity or could playing […]

Re:Cognition Health Shortlisted for Best in Primary Care and Diagnostics at the LaingBuisson Awards 2023

Re:Cognition Health is thrilled to announce that our team has been shortlisted as a finalist at the prestigious LaingBuisson Awards 2023 in the “Best in Primary Care […]

World Mental Health Day

To mark World Mental Health Day we thought it would be opportune to shed light on the mental health challenges associated with Long COVID. Also known as post- acute sequelae […]

Re:Cognition Health Leads UK’s Donanemab Clinical Trial

In the dynamic landscape of medical research and clinical trials, breakthroughs can have far-reaching impacts on healthcare and treatment options. The latest buzz in Alzheimer’s Research revolves […]

Celebrating the Success of Clinical Trial

International Clinical Trials Day 20th May 2023 “Taking part in clinical research gives us hope – the breakthrough may be just around the corner – and we […]

Re:Cognition Health becomes first network of clinical trial sites to have achieved GCSA Accredited status

London and Maidenhead, United Kingdom, 21 February 2023 – Re:Cognition Health’s commercial clinical research operational processes have undergone a rigorous evidence-based assessment to achieve all seven GCSA […]

Historical moment for Alzheimer’s treatment Re:Cognition Health proud to deliver lecanemab clinical trial

Re:Cognition Health’s Brain and Mind Experts are excited and proud to be delivering “Clarity“ the global clinical trial for Lecanemab, as the result of the trial is […]